Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Other financing activities (2020 - 2023)

Tango Therapeutics has reported Other financing activities over the past 2 years, most recently at $63000.0 for Q4 2023.

  • Quarterly results put Other financing activities at $63000.0 for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $7.2 million (changed N/A YoY), and the annual figure for FY2025 was $36000.0, changed.
  • Other financing activities for Q4 2023 was $63000.0 at Tango Therapeutics, down from $3.6 million in the prior quarter.
  • Over the last five years, Other financing activities for TNGX hit a ceiling of $3.6 million in Q3 2020 and a floor of $63000.0 in Q4 2023.